Michael Cloonan, M.B.A.

Michael Cloonan, M.B.A.

President and Chief Executive OfficeratSionna Therapeutics· In proxies 2023–2025

Pay in FY2025+87% from the year before

Michael Cloonan, M.B.A. was paid $7.0M in FY2025 (Dec), up 87%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Sionna Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sionna TherapeuticsPublic company · 3 yr
    • President and Chief Executive Officer2023 – Present · 3 yrStock in role -84%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?